Central Pacific Bank - Trust Division’s iShares Biotechnology ETF IBB Stock Holding History

Central Pacific Bank - Trust Division’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$951	Sell	5 -14,825	-100%	-$2.55M	﹤0.01%	837
2026 Q1	$2.5M	Hold	14,830	–	–	0.32%	81
2025 Q4	$2.5M	Buy	14,830 +14,825	+296,500%	+$2.41M	0.31%	79
2025 Q3	$722	Hold	5	–	–	﹤0.01%	813
2025 Q2	$633	Hold	5	–	–	﹤0.01%	822
2025 Q1	$640	Hold	5	–	–	﹤0.01%	829
2024 Q4	$661	Hold	5	–	–	﹤0.01%	866
2024 Q3	$728	Hold	5	–	–	﹤0.01%	839
2024 Q2	$686	Hold	5	–	–	﹤0.01%	925
2024 Q1	$684	Buy	+5	New	+$683	﹤0.01%	922

Other funds holding IBB

GIC

Generali Investments CEE Prague, Czech Republic $2.11B AUM 25.53% 1-Year Est. Return

IHL

Investment House LLC Redondo Beach, California $1.92B AUM 25.81% 1-Year Est. Return

Appleton Partners Boston, Massachusetts $1.63B AUM 38.57% 1-Year Est. Return

FMI

Factory Mutual Insurance Waltham, Massachusetts $10.6B AUM 34.1% 1-Year Est. Return

Cumberland Advisors Sarasota, Florida $284M AUM 27.11% 1-Year Est. Return

FNFDCM

Folger Nolan Fleming Douglas Capital Management Washington, District of Columbia $1.22B AUM 34.81% 1-Year Est. Return

Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return

RFA

Reyes Financial Architecture San Diego, California $179M AUM 31.17% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

Central Pacific Bank - Trust Division's IBB Position: Q2 2026 in Review

Central Pacific Bank - Trust Division reduced its iShares Biotechnology ETF (IBB) stake by 100% in Q2 2026, selling an estimated $2.55M and leaving 5 shares worth $951. The position accounts for ﹤0.01% of the portfolio, ranked #837.

Central Pacific Bank - Trust Division first reported a position in IBB in Q1 2024 and has held it in 10 quarters since. The position peaked at $2.5M in Q1 2026. 202 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Central Pacific Bank - Trust Division held 5 shares of iShares Biotechnology ETF worth $951 as of Q2 2026.
Central Pacific Bank - Trust Division sold 14,825 iShares Biotechnology ETF shares in Q2 2026, an estimated $2.55M.
iShares Biotechnology ETF made up ﹤0.01% of Central Pacific Bank - Trust Division's portfolio in Q2 2026, its #837 holding.
Central Pacific Bank - Trust Division first reported a position in iShares Biotechnology ETF in Q1 2024 and has held it in 10 quarters since.
Central Pacific Bank - Trust Division's iShares Biotechnology ETF position peaked at $2.5M in Q1 2026.
202 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Central Pacific Bank - Trust Division's 13F filing for Q2 2026, filed 7 Jul 2026.